Approved prospectus on admission of shares of Agrowill Group, AB to regulated markets

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THE STOCK EXCHANGE RELEASE.

        Print
| Source: Agrowill Group
multilang-release

On 31 March 2014 the Bank of Lithuania approved the prospectus on admission of new ordinary registered shares of Agrowill Group, AB (hereinafter, the “Company”) to trading on the regulated markets (AB NASDAQ OMX Vilnius and Warsaw Stock Exchange) (hereinafter, the “Prospectus”, please see the attached documents).

The approved Prospectus does not foresee the public offering of Company’s shares, and the Prospectus is designated solely for the purpose of admission of up to 102,595,266 units of Companys shares, to be newly issued during the increase of the authorised capital, to trading on the aforementioned regulated markets.

The new shares of the Company will be issued following the withdrawal of all the current Company’s shareholders the pre-emptive right to acquire the shares and entitling Baltic Champs Group, UAB and Vretola Holdings Limited to acquire them, having the aim to extend crop activities conducted by the group of companies of Agrowill Group, AB as well as to launch a champignon growing business and other activities in connection therewith, as it is foreseen by the decisions of the extraordinary general meeting of shareholders of the Company, dated 13 March 2014.

The Prospectus is published through GlobeNewswire, the on-line information system of AB NASDAQ OMX Vilnius, as well as through on-line information system of the Warsaw Stock Exchange and on the Company’s website http://www.agrowill.lt.

 

IMPORTANT NOTICE:

This notification is not for distribution to United States newswire services or for dissemination in the United States, Canada, Japan or Australia or elsewhere where such dissemination is not appropriate and/or is illegal.

Distribution of this announcement and other information in connection with the increase of the Company’s authorised capital may be restricted by law in certain jurisdictions. Persons into whose possession this notification or such other information should come are required to inform themselves about and to observe any such restrictions.

No offer or invitation to acquire securities of the Company is being made by or in connection with this notification and in connection with the Prospectus, which is designated exclusively for the purpose of admission of new shares of the Company to trading on the regulated markets. The Prospectus is the only legally binding document related to admission of new shares of the Company to trading on the indicated regulated markets, containing information on the Company, increase of its authorised capital under the decisions of the general meeting of shareholders of the Company, dated 13 March 2014, etc.

The securities referred to herein have not been and will not be registered under the US Securities Act of 1933, as amended, and may not be offered or sold in the United States or to US persons unless the securities are registered under the Securities Act, or an exemption from the registration requirements of the Securities Act is available. No public offering of the securities will be made in the United States and/or in any other states.

 

         Vladas Bagavičius
         Chairman of the Board
         +370 5 233 53 40